Solventum Corporation Common Stock SOLV 深 沪
等待开盘 08-07 09:30:00 美东时间
72.57
+0.140
+0.19%
华盛通- 最 高73.00
- 今 开72.90
- 成交量 87.93万股
- 最 低 71.445
- 昨 收 72.43
- 总市值 125.55亿
- 52周最高 85.92
- 市盈率 静 26.32
- 换手率 0.51%
- 52周最低 58.76
- 委 比 95.12%
- 总股本 1.73亿
- 历史最高 85.92
- 量 比 1.20
- 振 幅 2.15%
- 历史最低 47.16
- 每 手 1
- 风险率 6.40%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多制药巨头扎堆做“减法”：20家药企7月宣布裁员
2025 年已经过半，裁员、削减成本，成为众多药企不得不面对的现实。据 Fierce Biotech 统计，仅在今年 7 月，就有 20 家药企宣布了裁员计划...
08-01 12:49
Steris, Solventum upgraded, RxSight downgraded in Morgan Stanley's MedTech review
Reviewing its MedTech coverage ahead of the Q2 earnings season on Tuesday, Morgan Stanley upgraded Steris (NYSE:STE) and Solventum (NYSE:SOLV) to Overweight from Equal Weight and downgraded RxSight (N...
07-16 03:26
Morgan Stanley Upgrades Solventum to Overweight, Raises Price Target to $103
Morgan Stanley analyst Patrick Wood upgrades Solventum (NYSE:SOLV) from Equal-Weight to Overweight and raises the price target from $80 to $103.
07-15 21:01
Argus Research Upgrades Solventum to Buy
Argus Research analyst John Staszak upgrades Solventum (NYSE:SOLV) from Hold to Buy.
07-01 22:23
AI implementation propels salaries for top tech, information executives: report
The implementation of artificial intelligence systems has expanded the roles of chief technology officers, prompting compensation hikes across an array of sectors from consumer to financial services t...
07-01 21:21
传赛默飞世尔(TMO.US)拟以40亿美元出售部分诊断业务
据知情人士透露，赛默飞世尔正计划以约40亿美元的价格出售其诊断业务部门，此举旨在优化资产组合，剥离部分增长乏力的业务板块。
06-13 11:39
Keybanc Initiates Coverage On Solventum with Sector Weight Rating
Keybanc analyst Brett Fishbin initiates coverage on Solventum (NYSE:SOLV) with a Sector Weight rating.
06-06 20:00
美股大行评级 | 潜在涨幅300.0%！HC Wainwright & Co.：Armata Pharmaceuticals获机构升目标价至9美元，维持"买入"评级
潜在涨幅300.0%！HC Wainwright & Co.：Armata Pharmaceuticals获机构升目标价至9美元，维持"买入"评级
05-21 16:44
美股大行评级 | 摩根大通：维持网易"超配"评级，目标价升至135美元；瑞银上调达美航空评级至"买入"
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1131517965561573377.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Armata Pharmaceuticals(ARMP)"买入"评级，目标价从7美元升至9美元</p> <p>• 瑞银：维持爱芬奇(ANF)"买入"评级，目标价从115美
05-20 09:28
